⌘K

Login Start Free

Home/Filings/4/0000899243-22-004186

4//SEC Filing

Vavricka John 4

Accession 0000899243-22-004186

CIK 0001593899other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:15 PM ET

Size

5.4 KB

Accession

0000899243-22-004186

Insider Transaction Report

Form 4

Period: 2022-01-31

Atea Pharmaceuticals, Inc.AVIR

Chief Commercial Officer

Transactions

Award
Stock Option (Right to Buy)
2022-01-31+135,000→ 135,000 total
Exercise: $7.14Exp: 2032-01-30→ Common Stock (135,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Atea Pharmaceuticals, Inc.

CIK 0001593899

Entity typeother

Related Parties

1

filerCIK 0001829630

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 5:15 PM ET
Size: 5.4 KB

View on SEC.gov